/
AMPH
$20.18+$0.20 (+1.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$849.9M
43M shares
52-week range
$16.65 – $31.26
24% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change+$0.85
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
www.amphastar.com- Employees
- 1,976
- IPO / List date
- Jun 25, 2014
- HQ
- RANCHO CUCAMONGA, CA
Held by traders on TradeandTell
No one on the platform currently holds AMPH.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 553,900 | $10.9M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded AMPH yet.
